Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.59 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.59 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.59 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2351099 | 0.94 | ALDH1A1 (0.89) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8088391 | 0.92 | ALDH1A1 (0.85) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5081086 | 0.92 | ALDH1A1 (0.85) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL7820281 | 0.92 | ALDH1A1 (0.85) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL3943933 | 0.92 | ALDH1A1 (0.85) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL710248 | 0.92 | ALDH1A1 (0.85) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL1930794 | 0.87 | ALDH1A1 (0.77) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL3959624 | 0.86 | ALDH1A1 (0.75) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL9463394 | 0.85 | ALDH1A1 (0.73) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8160357 | 0.84 | ALDH1A1 (0.72) | ALDH1A1HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12544350-B2 | Combinatorial antitumor treatment methods and related compositions, kits, and systems | KLOTHO THERAPEUTICS, INC. (US) | 2026-02-10 | — | — | US | claimed |
| US-20240277650-A1 | NOVEL COMBINATORIAL ANTITUMOR TREATMENT METHODS AND RELATED COMPOSITIONS, KITS, AND SYSTEMS | KLOTHO THERAPEUTICS, INC. | 2024-08-22 | — | — | US | claimed |
| US-20240216514-A1 | NOVEL ANTITUMOR COMPOUNDS AND RELATED METHODS OF MANUFACTURE AND USE | KLOTHO THERAPEUTICS, INC. | 2024-07-04 | — | — | US | claimed |
| EP-4366716-A1 | NOVEL COMBINATORIAL ANTITUMOR TREATMENT METHODS AND RELATED COMPOSITIONS, KITS, AND SYSTEMS | Klotho Therapeutics, Inc. (US) | 2024-05-15 | — | — | EP | claimed |
| US-20230278953-A1 | WATER SOLUBLE PRODRUGS OF PTBA FOR USE IN HDAC INHIBITION AND ENHANCING RENAL RECOVERY FOLLOWING ACUTE KIDNEY INJURY | KLOTHO THERAPEUTICS, INC. | 2023-09-07 | — | — | US | claimed |
| EP-4178560-A1 | WATER SOLUBLE PRODRUGS OF PTBA FOR USE IN HDAC INHIBITION AND ENHANCING RENAL RECOVERY FOLLOWING ACUTE KIDNEY INJURY | Klotho Therapeutics, Inc. (US) | 2023-05-17 | — | — | EP | claimed |
| WO-2023283648-A1 | NOVEL COMBINATORIAL ANTITUMOR TREATMENT METHODS AND RELATED COMPOSITIONS, KITS, AND SYSTEMS | KLOTHO THERAPEUTICS, INC. (US) | 2023-01-12 | — | — | WO | claimed |
| WO-2022217255-A1 | NOVEL ANTITUMOR COMPOUNDS AND RELATED METHODS OF MANUFACTURE AND USE | KLOTHO THERAPEUTICS, INC. (US) | 2022-10-13 | — | — | WO | claimed |
| WO-2022011174-A1 | WATER SOLUBLE PRODRUGS OF PTBA FOR USE IN HDAC INHIBITION AND ENHANCING RENAL RECOVERY FOLLOWING ACUTE KIDNEY INJURY | KLOTHO THERAPEUTICS, INC. (US) | 2022-01-13 | — | — | WO | claimed |
| US-20200207691-A1 | Class of HDAC Inhibitors Expands the Renal Progenitor Cells Population and Improves the Rate of Recovery from Acute Kidney Injury | UNIVERSITY OF PITTSBURGH - OF T | 2020-07-02 | — | — | US | claimed |
| EP-1799638-B1 | PROCESS FOR PREPARING AROMATIC THIOPHENYL KETONES | CIBA HOLDING INC (CH) | 2008-07-30 | — | — | EP | claimed |
| EP-1799638-A1 | PROCESS FOR PREPARING AROMATIC THIOPHENYL KETONES | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2007-06-27 | — | — | EP | claimed |
| US-7045321-B2 | POLYHYDROXYALKANOATE CONTAINING UNIT WITH PHENYLSULFANYL STRUCTURE IN THE SIDE CHAIN, PROCESS FOR ITS PRODUCTION, CHARGE CONTROL AGENT, TONER BINDER AND TONER WHICH CONTAIN NOVEL POLYHYDROXYALKANOATE, AND IMAGE-FORMING METHOD AND IMAGE-FORMING APPARATUS WHICH MAKE USE OF THE TONER | CANON KABUSHIKI KAISHA (JP) | 2006-05-16 | — | — | US | claimed |
| WO-2006034966-A1 | PROCESS FOR PREPARING AROMATIC THIOPHENYL KETONES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-04-06 | — | — | WO | claimed |
| US-20030013841-A1 | Novel polyhydroxyalkanoate containing unit with phenylsulfanyl structure in the side chain, process for its production, charge control agent, toner binder and toner which contain novel polyhydroxyalkanoate, and image-forming method and image-forming apparatus which make use of the toner | CANON KABUSHIKI KAISHA (JP) | 2003-01-16 | — | — | US | claimed |
| EP-1236755-A2 | Novel polyhydroxyalkanoate containing unit phenylsulfanyl structure in the side cahin, process for its production, charge control agent, toner binder and toner which contain novel polyhydroxyalkanoate, and imageforming apparatus which make use of the toner | CANON KABUSHIKI KAISHA (JP) | 2002-09-04 | — | — | EP | claimed |
| EP-0850221-A1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1998-07-01 | — | — | EP | claimed |
| WO-1997008145-A1 | META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS | G.D. SEARLE & CO. (US) | 1997-03-06 | — | — | WO | claimed |
| EP-0505467-A1 | PHARMACOLOGICALLY ACTIVE AMIDE CARBOXYLATE DERIVATIVES | Astra Pharmaceuticals Limited (GB) | 1992-09-30 | — | — | EP | claimed |
| WO-1991008737-A2 | PHARMACOLOGICALLY ACTIVE AMIDE CARBOXYLATE DERIVATIVES | FISONS PLC (GB) | 1991-06-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230278953-A1 | WATER SOLUBLE PRODRUGS OF PTBA FOR USE IN HDAC INHIBITION AND ENHANCING RENAL RECOVERY FOLLOWING ACUTE KIDNEY INJURY | HDAC1, HDAC9, HDAC7 | ALDH1A1 111/4885HDAC3 4/4885HDAC4 8/4885 |
| US-12544350-B2 | Combinatorial antitumor treatment methods and related compositions, kits, and systems | TPMT, BCL2A1, XPA | ALDH1A1 615/4885HDAC3 4052/4885HDAC4 4442/4885 |
| US-20240277650-A1 | NOVEL COMBINATORIAL ANTITUMOR TREATMENT METHODS AND RELATED COMPOSITIONS, KITS, AND SYSTEMS | PTBP3, PTBP1, TYMS | ALDH1A1 504/4885HDAC3 1652/4885HDAC4 2228/4885 |
| US-20240216514-A1 | NOVEL ANTITUMOR COMPOUNDS AND RELATED METHODS OF MANUFACTURE AND USE | BID, TBCA, PTBP3 | ALDH1A1 168/4885HDAC3 553/4885HDAC4 673/4885 |
| US-20200207691-A1 | Class of HDAC Inhibitors Expands the Renal Progenitor Cells Population and Improves the Rate of Recovery from Acute Kidney Injury | HDAC1, HDAC9, HDAC11 | ALDH1A1 351/4885HDAC3 9/4885HDAC4 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.